Home
EGFR: The Challenge of Primary and Secondary Resistance
HMP Education
Oct 25, 2023
900 views
Evaluating Current and Emerging Targeted Therapies in Hepatocellular Carcinoma
The Era of ADCs in the Treatment of NSCLC
EGFR-Targeted Therapy for Early-Stage NSCLC: What Thoracic Surgeons Need to Know
ALK Positive Lung Cancer in 2023 and Beyond: Thinking Outside the Box with Dr. Alice Shaw
Refining Precision Decisions in NSCLC With Common and Less Common EGFR Mutations
How do doctors treat lung cancer with EGFR mutations?
The clinical use of tyrosine kinase inhibitors in EGFR-mutant NSCLC
Killing cancer with a breakthrough therapy | 60 Minutes Full Episodes
IASLC Webinar: World Conference on Lung Cancer 2020 Highlights
What You Need to Know about Non-Hodgkin's Lymphoma: Presentation
Updates in Front-Line Advances in Adjuvant and Targeted Treatment for Endometrial Cancer
Expert video report on amivantamab in combination therapy for 1L treatment in EGFRm, advanced NSCLC
IBD Abstracts | Nirupama N. Bonthala, MD
Small Cell Lung Cancer (SCLC) Algorithm - Drs. Rohit & Rahul Gosain with Dr. Estelamari Rodriguez
Keeping Up with IBS Treatment Strategies
Facilitating Progress in the Treatment of SCLC
Breakthroughs in Stopping Aging - Medical Frontiers
Unlock Updated Guidelines for the Treatment of RRMM
Full Recording of the September 2024 ICARE Genetics Case Conference
Glen Jeffery explains: the Science behind Mitochondrial Infra-Red (MIR)